163 related articles for article (PubMed ID: 27622020)
1. Extracellular HSP110 skews macrophage polarization in colorectal cancer.
Berthenet K; Boudesco C; Collura A; Svrcek M; Richaud S; Hammann A; Causse S; Yousfi N; Wanherdrick K; Duplomb L; Duval A; Garrido C; Jego G
Oncoimmunology; 2016 Jul; 5(7):e1170264. PubMed ID: 27622020
[TBL] [Abstract][Full Text] [Related]
2. HSP110 promotes colorectal cancer growth through STAT3 activation.
Berthenet K; Bokhari A; Lagrange A; Marcion G; Boudesco C; Causse S; De Thonel A; Svrcek M; Goloudina AR; Dumont S; Hammann A; Biard DS; Demidov ON; Seigneuric R; Duval A; Collura A; Jego G; Garrido C
Oncogene; 2017 Apr; 36(16):2328-2336. PubMed ID: 27819670
[TBL] [Abstract][Full Text] [Related]
3. Consequences of the Hsp110DE9 mutation in tumorigenesis and the 5-fluorouracil-based chemotherapy response in Msh2-deficient mice.
Noel K; Bokhari A'; Bertrand R; Renaud F; Bourgoin P; Cohen R; Svrcek M; Joly AC; Duval A; Collura A
Cell Mol Life Sci; 2022 Jun; 79(6):332. PubMed ID: 35648235
[TBL] [Abstract][Full Text] [Related]
4. Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.
Collura A; Lagrange A; Svrcek M; Marisa L; Buhard O; Guilloux A; Wanherdrick K; Dorard C; Taieb A; Saget A; Loh M; Soong R; Zeps N; Platell C; Mews A; Iacopetta B; De Thonel A; Seigneuric R; Marcion G; Chapusot C; Lepage C; Bouvier AM; Gaub MP; Milano G; Selves J; Senet P; Delarue P; Arzouk H; Lacoste C; Coquelle A; Bengrine-Lefèvre L; Tournigand C; Lefèvre JH; Parc Y; Biard DS; Fléjou JF; Garrido C; Duval A
Gastroenterology; 2014 Feb; 146(2):401-11.e1. PubMed ID: 24512910
[TBL] [Abstract][Full Text] [Related]
5. Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer.
Marcion G; Hermetet F; Neiers F; Uyanik B; Dondaine L; Dias AMM; Da Costa L; Moreau M; Bellaye PS; Collin B; Gobbo J; Briand L; Seigneuric R; Kitten O; Cinier M; Garrido C
Int J Cancer; 2021 Jun; 148(12):3019-3031. PubMed ID: 33506516
[TBL] [Abstract][Full Text] [Related]
6. Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.
Dorard C; de Thonel A; Collura A; Marisa L; Svrcek M; Lagrange A; Jego G; Wanherdrick K; Joly AL; Buhard O; Gobbo J; Penard-Lacronique V; Zouali H; Tubacher E; Kirzin S; Selves J; Milano G; Etienne-Grimaldi MC; Bengrine-Lefèvre L; Louvet C; Tournigand C; Lefèvre JH; Parc Y; Tiret E; Fléjou JF; Gaub MP; Garrido C; Duval A
Nat Med; 2011 Sep; 17(10):1283-9. PubMed ID: 21946539
[TBL] [Abstract][Full Text] [Related]
7. Advantage of
Berardinelli GN; Scapulatempo-Neto C; Durães R; Antônio de Oliveira M; Guimarães D; Reis RM
Oncotarget; 2018 Jun; 9(47):28691-28701. PubMed ID: 29983889
[TBL] [Abstract][Full Text] [Related]
8. Dominant high expression of wild-type HSP110 defines a poor prognostic subgroup of colorectal carcinomas with microsatellite instability: a whole-section immunohistochemical analysis.
Oh HJ; Kim JH; Lee TH; Park HE; Bae JM; Lee HS; Kang GH
APMIS; 2017 Dec; 125(12):1076-1083. PubMed ID: 28971530
[TBL] [Abstract][Full Text] [Related]
9. Major improvement in the detection of microsatellite instability in colorectal cancer using HSP110 T17 E-ice-COLD-PCR.
How-Kit A; Daunay A; Buhard O; Meiller C; Sahbatou M; Collura A; Duval A; Deleuze JF
Hum Mutat; 2018 Mar; 39(3):441-453. PubMed ID: 29227006
[TBL] [Abstract][Full Text] [Related]
10. Deletion in HSP110 T
Kim KJ; Lee TH; Kim JH; Cho NY; Kim WH; Kang GH
Hum Pathol; 2017 Sep; 67():109-118. PubMed ID: 28811251
[TBL] [Abstract][Full Text] [Related]
11. HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer.
Buhard O; Lagrange A; Guilloux A; Colas C; Chouchène M; Wanherdrick K; Coulet F; Guillerm E; Dorard C; Marisa L; Bokhari A; Greene M; El-Murr N; Bodo S; Muleris M; Sourouille I; Svrcek M; Cervera P; Blanché H; Lefevre JH; Parc Y; Lepage C; Chapusot C; Bouvier AM; Gaub MP; Selves J; Garrett K; Iacopetta B; Soong R; Hamelin R; Garrido C; Lascols O; André T; Fléjou JF; Collura A; Duval A
J Med Genet; 2016 Jun; 53(6):377-84. PubMed ID: 26831756
[TBL] [Abstract][Full Text] [Related]
12. Significant overexpression of Hsp110 gene during colorectal cancer progression.
Slaby O; Sobkova K; Svoboda M; Garajova I; Fabian P; Hrstka R; Nenutil R; Sachlova M; Kocakova I; Michalek J; Smerdova T; Knoflickova D; Vyzula R
Oncol Rep; 2009 May; 21(5):1235-41. PubMed ID: 19360299
[TBL] [Abstract][Full Text] [Related]
13. HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells.
Causse SZ; Marcion G; Chanteloup G; Uyanik B; Boudesco C; Grigorash BB; Douhard R; Dias AMM; Dumetier B; Dondaine L; Gozzi GJ; Moussay E; Paggetti J; Mirjolet C; de Thonel A; Dubrez L; Demidov ON; Gobbo J; Garrido C
Oncogene; 2019 Apr; 38(15):2767-2777. PubMed ID: 30542121
[TBL] [Abstract][Full Text] [Related]
14. Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy.
Gozzi GJ; Gonzalez D; Boudesco C; Dias AMM; Gotthard G; Uyanik B; Dondaine L; Marcion G; Hermetet F; Denis C; Hardy L; Suzanne P; Douhard R; Jego G; Dubrez L; Demidov ON; Neiers F; Briand L; Sopková-de Oliveira Santos J; Voisin-Chiret AS; Garrido C
Cell Death Differ; 2020 Jan; 27(1):117-129. PubMed ID: 31068676
[TBL] [Abstract][Full Text] [Related]
15. Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.
Popēna I; Ābols A; Saulīte L; Pleiko K; Zandberga E; Jēkabsons K; Endzeliņš E; Llorente A; Linē A; Riekstiņa U
Cell Commun Signal; 2018 Apr; 16(1):17. PubMed ID: 29690889
[TBL] [Abstract][Full Text] [Related]
16. Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.
Kimura A; Ogata K; Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Yanoma T; Suzuki M; Bai T; Oyama T; Kuwano H
Oncotarget; 2016 Apr; 7(14):18415-23. PubMed ID: 26943774
[TBL] [Abstract][Full Text] [Related]
17. HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma.
Manjili MH; Park J; Facciponte JG; Subjeck JR
Immunobiology; 2005; 210(5):295-303. PubMed ID: 16164037
[TBL] [Abstract][Full Text] [Related]
18. Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer.
Hwang TS; Han HS; Choi HK; Lee YJ; Kim YJ; Han MY; Park YM
J Gastroenterol Hepatol; 2003 Jun; 18(6):690-700. PubMed ID: 12753152
[TBL] [Abstract][Full Text] [Related]
19. Tumor Cells and the Extracellular Matrix Dictate the Pro-Tumoral Profile of Macrophages in CRC.
Coletta S; Lonardi S; Sensi F; D'Angelo E; Fassan M; Pucciarelli S; Valzelli A; Biccari A; Vermi W; Della Bella C; Barizza A; D'Elios MM; de Bernard M; Agostini M; Codolo G
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680345
[TBL] [Abstract][Full Text] [Related]
20. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.
Manjili MH; Henderson R; Wang XY; Chen X; Li Y; Repasky E; Kazim L; Subjeck JR
Cancer Res; 2002 Mar; 62(6):1737-42. PubMed ID: 11912148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
